Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Roshanak Amirian, Mehdi Azadi Badrbani, Zhila Izadi, Hadi Samadian, Gholamreza Bahrami, Sajad Sarvari, Sara Abdolmaleki, Seyed Mohammad Nabavi, Hossein Derakhshankhah & Mehdi Jaymand. (2023) Targeted protein modification as a paradigm shift in drug discovery. European Journal of Medicinal Chemistry 260, pages 115765.
Crossref
Crossref
Yongjin Hao, Jiawan Ma, Jin Wang, Xiaoliang Yu, Zhanhui Li, Shuwei Wu, Sheng Tian, Haikuo Ma, Sudan He & Xiaohu Zhang. (2023) Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors. European Journal of Medicinal Chemistry 258, pages 115616.
Crossref
Crossref
Himanshu Yadav & Raj Kumar Shirumalla. (2023) Emerging trends in IRAK-4 kinase research. Molecular Biology Reports 50:9, pages 7825-7837.
Crossref
Crossref
Vijayakumar Gosu, Santanu Sasidharan, Prakash Saudagar, Kamalakannan Radhakrishnan, Hak-Kyo Lee & Donghyun Shin. (2023) Deciphering the intrinsic dynamics of unphosphorylated IRAK4 kinase bound to type I and type II inhibitors. Computers in Biology and Medicine 160, pages 106978.
Crossref
Crossref
Ismail Sami Mahmoud, Yazun Bashir Jarrar & Febrimarsa. (2023) Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm. Clinical and Experimental Medicine.
Crossref
Crossref
Saynaz A. Choudhary, Debarun Patra, Archana Sinha, Sayani Mazumder, Rajat Pant, Raju Chouhan, Anupam Nath Jha, Biswa Mohan Prusty, Debasis Manna, Sajal K. Das, Kulbhushan Tikoo, Durba Pal & Suman Dasgupta. (2023) A small molecule potent IRAK4 inhibitor abrogates lipopolysaccharide-induced macrophage inflammation in-vitro and in-vivo. European Journal of Pharmacology 944, pages 175593.
Crossref
Crossref
Jiaxin Tian, Kunyu Li, Guanghai Ma, Yong Cui & Feng Gao. (2023) An Immune-suppressive Triterpenoid from the Stem of Kadsura coccinea. Letters in Organic Chemistry 20:3, pages 250-253.
Crossref
Crossref
Natalia Turosz, Kamila Chęcińska, Maciej Chęciński, Monika Kamińska, Zuzanna Nowak, Maciej Sikora & Dariusz Chlubek. (2022) A Scoping Review of the Use of Pioglitazone in the Treatment of Temporo-Mandibular Joint Arthritis. International Journal of Environmental Research and Public Health 19:24, pages 16518.
Crossref
Crossref
Jun Liu, Hui Zhang, Yanhong Su & Baojun Zhang. (2022) Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases. Cell & Bioscience 12:1.
Crossref
Crossref
Yang Zhang, Xiaoyi Chen, Huamin Wang, Shanisha Gordon-Mitchell, Srabani Sahu, Tushar D. Bhagat, Gaurav Choudhary, Srinivas Aluri, Kith Pradhan, Plabani Sahu, Milagros Carbajal, Hui Zhang, Beamon Agarwal, Aditi Shastri, Robert Martell, Daniel Starczynowski, Ulrich Steidl, Anirban Maitra & Amit Verma. (2022) Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Eirini Maria Stergioti, Theodora Manolakou, Dimitrios T. Boumpas & Aggelos Banos. (2022) Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting. Biomedicines 10:11, pages 2820.
Crossref
Crossref
Mireia Sueca-Comes, Elena Cristina Rusu, Anna M. Grabowska & David O. Bates. (2022) Looking Under the Lamppost: The Search for New Cancer Targets in the Human Kinome. Pharmacological Reviews 74:4, pages 1136-1145.
Crossref
Crossref
Qianqian Li, Rui Li, Hanlin Yin, Suli Wang, Bei Liu, Jun Li, Mi Zhou, Qingran Yan & Liangjing Lu. (2022) Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome. Biomedicine & Pharmacotherapy 153, pages 113459.
Crossref
Crossref
Pritha Shah, Aqsa Siddique, Ami Thakkar, Sankalp Gharat, Angel Godad, Pravin Kale & Gaurav Doshi. (2022) An update on novel therapeutic intervention in Rheumatoid arthritis. International Immunopharmacology 109, pages 108794.
Crossref
Crossref
Andrew D. Gaulden & Jayme R. McReynolds. (2022) A rock in the toll road: IRAK4 inhibition of TLR4-MyD88 signaling as potential treatment for addiction. Brain, Behavior, and Immunity 104, pages 74-75.
Crossref
Crossref
Sania Aslam, Waqas Younis, Muhammad Nasir Hayat Malik, Shah Jahan, Alamgeer, Ambreen Malik Uttra, Muhammad Usman Munir & Muhammad Roman. (2022) Pharmacological evaluation of anti-arthritic potential of terpinen-4-ol using in vitro and in vivo assays. Inflammopharmacology 30:3, pages 945-959.
Crossref
Crossref
Miklós Békés, David R. Langley & Craig M. Crews. (2022) PROTAC targeted protein degraders: the past is prologue. Nature Reviews Drug Discovery 21:3, pages 181-200.
Crossref
Crossref
Dirk Föll & Tilmann Kallinich. 2022. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
291
309
.
Yoshiya Tanaka. (2021) Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs. Rheumatology 60:Supplement_6, pages vi12-vi20.
Crossref
Crossref
Mariana J. Kaplan. (2021) Targeting the Myddosome in Systemic Autoimmunity: Ready for Prime Time?. Arthritis & Rheumatology 73:12, pages 2163-2165.
Crossref
Crossref
Haixia Li, Shan Liu, Jinming Han, Shengxian Li, Xiaoyan Gao, Meng Wang, Jie Zhu & Tao Jin. (2021) Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems. Frontiers in Immunology 12.
Crossref
Crossref
Tsvetana Petrova, Sambit K Nanda, Cheryl Scudamore, Stephen W Wright, Vikram R Rao & Philip Cohen. (2021) Prevention and partial reversion of the lupus phenotype in ABIN1[D485N] mice by an IRAK4 inhibitor. Lupus Science & Medicine 8:1, pages e000573.
Crossref
Crossref
Di Zhan & Christopher Y. Park. (2021) Stem Cells in the Myelodysplastic Syndromes. Frontiers in Aging 2.
Crossref
Crossref
Jie Huang, Xuekun Fu, Xinxin Chen, Zheng Li, Yuhong Huang & Chao Liang. (2021) Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Frontiers in Immunology 12.
Crossref
Crossref
Philip Cohen, Darren Cross & Pasi A. Jänne. (2021) Kinase drug discovery 20 years after imatinib: progress and future directions. Nature Reviews Drug Discovery 20:7, pages 551-569.
Crossref
Crossref
Nicholas Stoy. (2021) Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19. Frontiers in Immunology 12.
Crossref
Crossref
Jiamin Zheng, Jun Wu, Xiao Ding, Hong C. Shen & Ge Zou. (2021) Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 38, pages 127862.
Crossref
Crossref
Simon Fillatreau, Benoît Manfroi & Thomas Dörner. (2020) Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nature Reviews Rheumatology 17:2, pages 98-108.
Crossref
Crossref
Adam G. Schwaid & Kerrie B. Spencer. (2020) Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space. Journal of Medicinal Chemistry 64:1, pages 101-122.
Crossref
Crossref
Dirk Föll & Tilmann Kallinich. 2020. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
1
19
.
Isabel Hodl, Philipp Bosch, Barbara Dreo & Martin H. Stradner. (2020) Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome. Frontiers in Immunology 11.
Crossref
Crossref